Skip to main content Accessibility help
×
Home

Surgical Site Infections After Liver Transplantation: Prospective Surveillance and Evaluation of 250 Transplant Recipients in Canada

  • Yoichiro Natori (a1) (a2), Rawan Kassar (a1) (a2), Aled Iaboni (a1), Seyed M. Hosseini-Moghaddam (a1) (a3), James Vu (a1) (a2), Shahid Husain (a1) (a2), Eberhard L. Renner (a1) (a4), David Grant (a1) (a5) and Coleman Rotstein (a1) (a2)...

Abstract

OBJECTIVE

To evaluate the incidence of surgical-site infections (SSIs) in a cohort of liver transplant recipients and to assess risk factors predisposing patients to these infections.

DESIGN

Prospective observational cohort study.

SETTING

Single transplant center in Canada.

PATIENTS

Patients who underwent liver transplantation between February 2011 and August 2014.

METHODS

Multivariate logistic regression was used to identify independent risk factors for SSIs in liver transplant patients.

RESULTS

We enrolled 250 liver transplant recipients. The recipients’ median age at the time of transplantation was 56 years (range, 19–70 years), and 166 patients (66.4%) were male. Moreover, 47 SSIs were documented in 43 patients (17.2%). Organ-space, superficial, and deep SSIs were noted in 29, 7, and 3 patients, respectively. In addition, 2 patients developed superficial and organ-space SSIs, and another 2 patients were found to have deep as well as organ-space infections. In total, we identified 33 organ-space SSIs (70.2%), 9 superficial SSIs (19.1%), and 5 deep SSIs (10.6%). Factors predictive of SSIs by multivariate analysis were duct-to-duct anastomosis (odds ratio [OR], 3.88; 95% CI, 1.85–8.13; P<.001) and dialysis (OR, 3.57; 95% CI, 1.02–12.50; P=.046). Of the 66 organisms isolated in both deep and organ-space SSIs, 55 (83%) were resistant to cefazolin.

CONCLUSIONS

Organ-space SSIs are a common complication after liver transplantation. Duct-to-duct anastomosis and dialysis were independent risk factors associated with SSIs. Appropriate perioperative prophylaxis targeting patients with duct-to-duct anastomosis and dialysis while simultaneously providing optimum coverage for the potential pathogens causing SSIs is warranted.

Infect Control Hosp Epidemiol 2017;38:1084–1090

Copyright

Corresponding author

Address correspondence to Coleman Rotstein, MD, University Health Network, Toronto General Hospital, 200 Elizabeth Street, PMB 11-139, Toronto, Ontario M5G 2C4 (Coleman.Rotstein@uhn.ca).

References

Hide All
1. Asensio, A, Ramos, A, Cuervas-Mons, V, et al. Effect of antibiotic prophylaxis on the risk of surgical site infection in orthotopic liver transplant. Liver Transpl 2008;14:799805.
2. García Prado, ME, Matia, EC, Ciuro, FP, et al. Surgical site infection in liver transplant recipients: impact of the type of perioperative prophylaxis. Transplantation 2008;85:18491854.
3. Kawecki, D, Chmura, A, Pacholczyk, M, et al. Surgical site infections in liver recipients in the early posttransplantation period: etiological agents and susceptibility profiles. Transplant Proc 2007;39:28002806.
4. Mehrabi, A, Fonouni, H, Wente, M, et al. Wound complications following kidney and liver transplantation. Clin Transplant 2006;20(Suppl 17):97110.
5. Klevens, RM, Edwards, JR, Richards, CL, et al. Estimating health care-associated infections and deaths in US hospitals, 2002. Public Health Rep 2007;122:160166.
6. Cruse, P. Wound infection surveillance. Rev Infect Dis 1981;3:734737.
7. Zimlichman, E, Henderson, D, Tamir, O, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med 2013;173:20392046.
8. Anderson, DJ, Kaye, KS, Chen, LF, et al. Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multi-center matched outcomes study. PLoS One 2009;4:e8305.
9. Prevention CfDCa. Surgical Site Infection (SSI) Event. Centers for Disease Control and Prevention website. http://www.cdc.gov/nhsn/PDFs/pscmanual/9pscssicurrent.pdf. Published 2016. Accessed November 24, 2016.
10. Mangram, AJ, Horan, TC, Pearson, ML, Silver, LC, Jarvis, WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999;20:250278.
11. Iinuma, Y, Senda, K, Fujihara, N, et al. Surgical site infection in living-donor liver transplant recipients: a prospective study. Transplantation 2004;78:704709.
12. Kusne, S. Regarding the risk for development of surgical site infections and bacterial prophylaxis in liver transplantation. Liver Transpl 2008;14:747749.
13. Hollenbeak, CS, Alfrey, EJ, Souba, WW. The effect of surgical site infections on outcomes and resource utilization after liver transplantation. Surgery 2001;130:388395.
14. Narayanan Menon, KV, Nyberg, SL, Harmsen, WS, et al. MELD and other factors associated with survival after liver transplantation. Am J Transplant 2004;4:819825.
15. Matsuo, K, Sekido, H, Morioka, D, et al. Surveillance of perioperative infections after adult living donor liver transplantation. Transplant Proc 2004;36:22992301.
16. Hellinger, WC, Crook, JE, Heckman, MG, et al. Surgical site infection after liver transplantation: risk factors and association with graft loss or death. Transplantation 2009;87:13871393.
17. Beltangady, M, Knupp, CA, Gustafson, N, et al. Relation between plasma concentrations of didanosine and markers of antiviral efficacy in adults with AIDS or AIDS-related complex. Clin Infect Dis 1993;16(Suppl 1):S26S31.
18. Viehman, JA, Clancy, CJ, Clarke, L, et al. Surgical site infections after liver transplantation: emergence of multidrug-resistant bacteria and implications for prophylaxis and treatment strategies. Transplantation 2016;100:21072114.
19. Moreno, A, Cervera, C, Gavaldá, J, et al. Bloodstream infections among transplant recipients: results of a nationwide surveillance in Spain. Am J Transplant 2007;7:25792586.
20. Yamamoto, M, Takakura, S, Iinuma, Y, et al. Changes in surgical site infections after living donor liver transplantation. PLoS One 2015;10:e0136559.
21. McElroy, LM, Daud, A, Davis, AE, et al. A meta-analysis of complications following deceased donor liver transplant. Am J Surg 2014;208:605618.
22. Ozaki, CF, Katz, SM, Monsour, HP, Dyer, CH, Wood, RP. Surgical complications of liver transplantation. Surg Clin North Am 1994;74:11551167.
23. Kusne, S, Dummer, JS, Singh, N, et al. Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) 1988;67:132143.
24. Keating, MR, Wilhelm, MP. Management of infectious complications following liver transplantation. Curr Clin Top Infect Dis 1993;13:226249.
25. Kato, S, Chmielewski, M, Honda, H, et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 2008;3:15261533.
Type Description Title
WORD
Supplementary materials

Natori supplementary material
Tables S1 and S2

 Word (23 KB)
23 KB

Surgical Site Infections After Liver Transplantation: Prospective Surveillance and Evaluation of 250 Transplant Recipients in Canada

  • Yoichiro Natori (a1) (a2), Rawan Kassar (a1) (a2), Aled Iaboni (a1), Seyed M. Hosseini-Moghaddam (a1) (a3), James Vu (a1) (a2), Shahid Husain (a1) (a2), Eberhard L. Renner (a1) (a4), David Grant (a1) (a5) and Coleman Rotstein (a1) (a2)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed